Hello all I’m generally a fly on the wall, but I want to hear some opinions about my concern.
I’m longish, got in on the first big run made really good money, now I’m
back because I think it’ll run again. I’ve order products from them, Also saw the free marketing on CNN about the FDA issuing a warning letter about false claims. Also researched the new auditors which seem surprisingly not sketchy!
So here’s my concern/question: the share count and the run.
Since these guys have 600+ million outstanding shares a run to a $1.00 puts their market cap above other companies like CV Sciences, even KUSHCO Holdings. Both companies do more in sales, and have lower share counts. Since their revenues are less than those companies is it more realistic to expect a run to around $.30-$.50 For a market cap of $180-$300 million? How big of a deal is that 600 million share count in correlation to the share price? Does anyone expect a possible buyout or reverse split?
All I know is CBD isn’t going away, and this company could make some serious revenues along with several others.